返回 Agenda
Session Chair(s)
Sara Doshi, PHARMD
Senior Director, Decentralized Clinical Trials
Eli Lilly and Company, United States
Learning Objective : At the conclusion of this session, participants should be able to: -Describe considerations and methodology for setting up an outsourcing service - Discuss practicalities of a pilot model - Recognize how learnings from other experiences may effect the parent organization - Explain how different outsourcing models may or may not bring value to the organization
Speaker(s)
Faculty
Jay Kissel, PHD
Eli Lilly and Company, United States
Consultant, Medical Information
Faculty
Loree Levine, MS, RPH
Bristol-Myers Squibb, United States
Associate Director, Global Medical Information
Faculty
Alexander Danyluk, PHARMD
Janssen Scientific Affairs, United States
Director Medical Information